Dri Healthcare Trust T.DHT.UN

Alternate Symbol(s): DHTRF

Healthcare Biotechnology

DRI Healthcare Trust is a Canada-based company engaged in global pharmaceutical royalty monetization. The Company is involved in pharmaceutical royalty monetization and provides capital to inventors, academic institutions and biopharma companies. It acquires more than 25 royalties on 20-plus drugs, including Eylea, Orserdu, Omidria, Spinraza, Stelara, Vonjo, Zejula and Zytiga. Its portfolio includes Empaveli/Syfovre, Eylea I, Eylea II, Ilaris, Natpara, Omidria, Oracea, Orserdu I, Orserdu II, Rydapt, Simponi, Spinraza, Stelara, Vonjo I, Vonjo II, Xenpozyme, Xolair, Zejula, Zytiga, sebetralstat, and others. Its therapeutic areas include hematology, ophthalmology, influenza, endocrinology, dermatology, oncology, neurology, immunology, lysosomal storage disorder, hereditary angioedema, and others. The Company is managed by DRI Capital Inc. Its products are marketed by pharmaceutical companies, including Regeneron, Bayer, Santen; AstraZeneca; Takeda; Galderma Laboratories; and others.

TSX:DHT.UN - Post by User

Dri Healthcare Trust

<< Previous

Bullboard Posts

Next >>

(32)
•••

Comment by junglejameson Sep 10, 2024 9:25am

90 Views

Post# 36216376

RE:RE:RE:RE:RE:NCIB tapped out...

SOF:

A number of factors are influencing the current share price :

a) the performance risk has increased - the new senior management is largely untested
b) dropping interest rates is now causing rotation into "secure" dividend stocks
c) managements NCIB is out of ammo (likely until November when it can be renewed)

This is a great opportunity for those that swim against the tide and are prepared to wait for their investment to pay-off.

I also think that equity markets are generally less "rational" owing to many new entrants post Covid and the ease of executing a transaction almost anywhere at anytime with low to nil transaction costs that has been influenced by automated price change notifications and other "information". Patience and "sober second thought" are in short supply everywhere. But then I'm old and that is likely my bias.

<< Previous

Bullboard Posts

Next >>

The fast track to gold production is underway in Nevada